Five years of safety profile of bevacizumab: an analysis of real-world pharmacovigilance and randomized clinical trials

• Main Authors: Li Wang (Author), Yibo Fei (Author), Han Qu (Author), Haiyang Zhang (Author), Yuanyuan Wang (Author), Zhenghua Wu (Author), Guorong Fan (Author)
• Format: Book
• Published: BMC, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Objective Bevacizumab is a monoclonal antibody against vascular endothelial growth factor. It has a wide range of clinical applications in various cancers and retinal diseases. The drugs entered the Chinese market by a large margin in 2017, and the user population changed to some extent. Th...